Nexien BioPharmaNXEN 
$0.010.00%24h
0.00%24h
Global rank
Market cap$374.00K
Change 7d0.00%
YTD Performance-83.33%
SP500 benchmarkUnderperform
P/E-0.60
P/S0
Revenue$0
Earnings-$361.90K
Dividend yield-
Main Sector
Healthcare
Nexien BioPharma (NXEN) Cash on Hand
NXEN Cash on Hand in 2022: $35.15K
According to Nexien BioPharma latest financial reports the cash on hand of NXEN is $35.15K, an decrease of -69.93% to 2022. At the end of 2022 company had $116.90K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
NXEN Cash on Hand History from 2019 to 2023
-
Value:-
NXEN Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $35.15K | -69.93% |
| 2022 | $116.90K | 547.96% |
| 2021 | $18.04K | 67.26% |
| 2020 | $10.79K | -92.63% |
| 2019 | $146.36K | - |
View the Top Cash on Hand Companies 
